Literature DB >> 25732274

Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys.

Rennatus Mdodo, Emma L Frazier, Shanta R Dube, Christine L Mattson, Madeline Y Sutton, John T Brooks, Jacek Skarbinski.   

Abstract

BACKGROUND: The negative health effects of cigarette smoking and HIV infection are synergistic.
OBJECTIVE: To compare the prevalence of current cigarette smoking and smoking cessation between adults with HIV receiving medical care and adults in the general population.
DESIGN: Nationally representative cross-sectional surveys.
SETTING: United States. PATIENTS: 4217 adults with HIV who participated in the Medical Monitoring Project and 27 731 U.S. adults who participated in the National Health Interview Survey in 2009. MEASUREMENTS: The main exposure was cigarette smoking. The outcome measures were weighted prevalence of cigarette smoking and quit ratio (ratio of former smokers to the sum of former and current smokers).
RESULTS: Of the estimated 419 945 adults with HIV receiving medical care, 42.4% (95% CI, 39.7% to 45.1%) were current cigarette smokers, 20.3% (CI, 18.6% to 22.1%) were former smokers, and 37.3% (CI, 34.9% to 39.6%) had never smoked. Compared with the U.S. adult population, in which an estimated 20.6% of adults smoked cigarettes in 2009, adults with HIV were nearly twice as likely to smoke (adjusted prevalence difference, 17.0 percentage points [CI, 14.0 to 20.1 percentage points]) but were less likely to quit smoking (quit ratio, 32.4% vs. 51.7%). Among adults with HIV, factors independently associated with greater smoking prevalence were older age, non-Hispanic white or non-Hispanic black race, lower educational level, poverty, homelessness, incarceration, substance use, binge alcohol use, depression, and not achieving a suppressed HIV viral load. LIMITATION: Cross-sectional design with some generalizability limitations.
CONCLUSION: Adults with HIV were more likely to smoke and less likely to quit smoking than the general adult population. Tobacco screening and cessation strategies are important considerations as part of routine HIV care.

Entities:  

Mesh:

Year:  2015        PMID: 25732274     DOI: 10.7326/M14-0954

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  208 in total

1.  Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and Research.

Authors:  Robert A Schnoll; Morgan Thompson; Katrina Serrano; Frank Leone; David Metzger; Ian Frank; Robert Gross; Karam Mounzer; Rachel F Tyndale; Jessica Weisbrot; Miles Meline; Ronald G Collman; Rebecca L Ashare
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

2.  Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study.

Authors:  Aaron P Thrift; Jennifer R Kramer; Christine M Hartman; Kathryn Royse; Peter Richardson; Yongquan Dong; Suchismita Raychaudhury; Roxanne Desiderio; Dina Sanchez; Sharmila Anandasabapathy; Donna L White; Elizabeth Y Chiao
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

3.  Measurement of Current Substance Use in a Cohort of HIV-Infected Persons in Continuity HIV Care, 2007-2015.

Authors:  Catherine R Lesko; Alexander P Keil; Richard D Moore; Geetanjali Chander; Anthony T Fojo; Bryan Lau
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

Review 4.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 5.  Modulatory Effects of Nicotine on neuroHIV/neuroAIDS.

Authors:  Haijun Han; Zhongli Yang; Sulie L Chang; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-13       Impact factor: 4.147

6.  Perceived Interrelations of Pain and Cigarette Smoking in a Sample of Adult Smokers Living With HIV/AIDS.

Authors:  Andrea H Weinberger; Elizabeth K Seng; Joseph W Ditre; Melody Willoughby; Jonathan Shuter
Journal:  Nicotine Tob Res       Date:  2019-03-30       Impact factor: 4.244

Review 7.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

8.  Feasibility of a Smartphone-Based Tobacco Treatment for HIV-Infected Smokers.

Authors:  Jonathan Shuter; Ryung S Kim; Lawrence C An; Lorien C Abroms
Journal:  Nicotine Tob Res       Date:  2020-03-16       Impact factor: 4.244

Review 9.  Renal effects of novel antiretroviral drugs.

Authors:  James Milburn; Rachael Jones; Jeremy B Levy
Journal:  Nephrol Dial Transplant       Date:  2017-03-01       Impact factor: 5.992

Review 10.  Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.

Authors:  Emma Kaplan-Lewis; Judith A Aberg; Mikyung Lee
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.